Morgan Stanley Bausch Health Companies Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Morgan Stanley holds 354,806 shares of BHC stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

354,806

Previous 504,250 29.64%

Holding current value

$2.62 Million

Previous $3.51 Million 17.73%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $780,097 - $1.23 Million	-149,444 Reduced 29.64%	354,806 $2.89 Million
Q2 2024 Oct 17, 2024	SELL	$6.1 - $10.41 $9.7 Million - $16.5 Million	-1,589,595 Reduced 75.92%	504,250 $3.51 Million
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $9.7 Million - $16.5 Million	-1,589,595 Reduced 75.92%	504,250 $3.51 Million
Q1 2024 Oct 17, 2024	BUY	$7.77 - $10.61 $12.4 Million - $16.9 Million	1,589,595 Added 315.24%	2,093,845 $22.2 Million
Q1 2024 Aug 16, 2024	SELL	$7.77 - $10.61 $761,397 - $1.04 Million	-97,992 Reduced 4.47%	2,093,845 $22.2 Million
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $761,397 - $1.04 Million	-97,992 Reduced 4.47%	2,093,845 $22.2 Million
Q4 2023 Aug 16, 2024	BUY	$6.53 - $8.23 $11 Million - $13.9 Million	1,687,587 Added 334.67%	2,191,837 $17.6 Million
Q4 2023 Feb 13, 2024	BUY	$6.53 - $8.23 $10.2 Million - $12.8 Million	1,558,816 Added 246.25%	2,191,837 $17.6 Million
Q3 2023 Nov 15, 2023	SELL	$7.69 - $9.71 $261,467 - $330,149	-34,001 Reduced 5.1%	633,021 $5.2 Million
Q2 2023 Aug 14, 2023	SELL	$5.72 - $8.8 $32.9 Million - $50.6 Million	-5,750,576 Reduced 89.61%	667,022 $5.34 Million
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $30.3 Million - $47.5 Million	4,821,431 Added 302.06%	6,417,598 $52 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $3.03 Million - $3.95 Million	498,042 Added 45.35%	1,596,167 $10 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $6.94 Million - $14 Million	-1,515,184 Reduced 57.98%	1,098,125 $7.57 Million
Q2 2022 Oct 27, 2022	SELL	$7.06 - $23.63 $5.05 Million - $16.9 Million	-714,649 Reduced 21.47%	2,613,309 $21.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $5.05 Million - $16.9 Million	-714,649 Reduced 21.47%	2,613,309 $21.8 Million
Q1 2022 Oct 27, 2022	BUY	$21.6 - $27.79 $15.4 Million - $19.9 Million	714,649 Added 27.35%	3,327,958 $76 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $6.23 Million - $8.01 Million	288,336 Added 9.49%	3,327,958 $76 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $33.1 Million - $41.7 Million	-1,438,044 Reduced 32.12%	3,039,622 $83.9 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $112 Million - $135 Million	4,477,666 New	4,477,666 $125 Million

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account